A "two-hit" (chemo)therapy to improve checkpoint inhibition in cancer

Oncoscience. 2021 May 7:8:55-57. doi: 10.18632/oncoscience.533. eCollection 2021.

Paolo Falvo^{1

2}, Stefania Orecchioni^{1

2}, Alessandro Raveane^{1

2}, Giulia Mitola¹, Francesco Bertolini¹

¹ Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan 20141, Italy.
² Contributed equally to this work.

No abstract available

Keywords: T-cell therapy; anti-PD-1; breast cancer; chemotherapy; immunotherapy; lymphoma.